Trial Profile
A Prospective, Randomized, 3-arm Parallel Trial to Evaluate the Safety and Clinical Effectiveness of 2 Lower Dose Combined PDE5i's vs. Single Maximal Dose PDE5i Treatment.
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 20 Jan 2020
Price :
$35
*
At a glance
- Drugs Sildenafil (Primary) ; Tadalafil (Primary)
- Indications Erectile dysfunction
- Focus Therapeutic Use
- 04 Jun 2011 New trial record